{"cluster": 48, "subcluster": 118, "abstract_summ": "The severe COVID-19 group had older patients and a higher male ratio than the non-severe group.The severe COVID-19 group had older patients and a proportion of male ratio than did the non-severe group.Background: Patients with pre-existing cirrhosis are considered at increased risk of severe coronavirus disease 2019 (COVID-19) but the clinical course in these patients has not yet been reported.Multivariable analysis showed that length of stay (odds ratio (OR): 2.02; 95% confidence interval (CI) 1.03\u20133.96; P = 0.04), number of drugs used in the hospital (OR: 3.17; 95% CI 1.60\u20136.27; P = 0.001) and underlying basic diseases (OR: 2.07; 95% CI 1.02\u20134.23; P = 0.04) were independent risk factor for ADRs in the patients.Rationale: Up to date, the exploration of clinical features in severe COVID-19 patients were mostly from the same center in Wuhan, China.", "title_summ": "Clinical course and risk factors for mortality of COVID-19 patients with pre-existing cirrhosis: A multicenter cohort studyMultiple Myeloma and SARS-CoV-2 Infection: Clinical Characteristics and Prognostic Factors of Inpatient MortalityHospitalization time and outcome in patients with Coronavirus Disease 2019 (COVID-19): analysis data from ChinaEffect of underlying comorbidities on the infection and severity of COVID-19 in South KoreaIncidence of Adverse Drug Reactions in COVID\u201019 Patients in China: An Active Monitoring Study by Hospital Pharmacovigilance SystemSex Differences in COVID-19 Case Fatality Rate:Insights From a Multinational RegistryEffect of Underlying Comorbidities on the Infection and Severity of COVID-19 in Korea: a Nationwide Case-Control StudyFactors associated with death outcome in patients with severe coronavirus disease-19 (COVID-19): a case-control studyAdenovirus Infection and Subsequent Risk of Kawasaki Disease: A Population-based Cohort Study.", "title_abstract_phrases": "Multiple Myeloma and SARS-CoV-2 Infection: Clinical Characteristics and Prognostic Factors of Inpatient MortalityThere is limited information on the characteristics, pre-admission prognostic factors, and outcomes of patients with multiple myeloma (MM) hospitalized with coronavirus disease 2019 (COVID-19).Clinical course and risk factors for mortality of COVID-19 patients with pre-existing cirrhosis: A multicenter cohort studyBackground: Patients with pre-existing cirrhosis are considered at increased risk of severe coronavirus disease 2019 (COVID-19) but the clinical course in these patients has not yet been reported.The severe COVID-19 group had older patients and a higher male ratio than the non-severe group.The severe COVID-19 group had older patients and a proportion of male ratio than did the non-severe group.Among the MM and non-cancer patients, median age was 71 years and 57% of patients were male in each series, and 75% and 77% of patients, respectively, had at least one comorbidity."}